Home Fluorides 448-19-1
448-19-1,MFCD00077541
Catalog No.:AA003MOG

448-19-1 | 5-Fluoro-2-nitroanisole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$6.00   $4.00
- +
5g
98%
in stock  
$7.00   $5.00
- +
10g
98%
in stock  
$9.00   $7.00
- +
25g
98%
in stock  
$12.00   $8.00
- +
100g
98%
in stock  
$14.00   $10.00
- +
500g
98%
in stock  
$61.00   $43.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003MOG
Chemical Name:
5-Fluoro-2-nitroanisole
CAS Number:
448-19-1
Molecular Formula:
C7H6FNO3
Molecular Weight:
171.1258
MDL Number:
MFCD00077541
SMILES:
COc1cc(F)ccc1[N+](=O)[O-]
Properties
Properties
 
BP:
272 °C at 760 mmHg  
Form:
Solid  
MP:
49 - 50 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
171  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Rotatable Bond Count:
1  
XLogP3:
1.7  

Upstream Synthesis Route

[1]TetrahedronLetters,2009,vol.50,#27,p.3776-3779

[1]JournalofOrganicChemistryUSSR(EnglishTranslation),1985,vol.21,#11,p.2173-2178

[2]ZhurnalOrganicheskoiKhimii,1985,vol.21,#11,p.2376-2382

[1]JournalofOrganicChemistryUSSR(EnglishTranslation),1985,vol.21,#11,p.2173-2178

[2]ZhurnalOrganicheskoiKhimii,1985,vol.21,#11,p.2376-2382

[3]JournalofOrganicChemistryUSSR(EnglishTranslation),1985,vol.21,#11,p.2173-2178

[4]ZhurnalOrganicheskoiKhimii,1985,vol.21,#11,p.2376-2382

[1]ChemicalandPharmaceuticalBulletin,1991,vol.39,#9,p.2323-2332

[2]Patent:CN106083536,2016,A,.Locationinpatent:Paragraph0035;0036

[3]Heterocycles,1992,vol.34,#12,p.2301-2311

[4]Patent:WO2010/71885,2010,A1,.Locationinpatent:Page/Pagecolumn443

[5]Patent:WO2010/115688,2010,A1,.Locationinpatent:Page/Pagecolumn146

[1]Patent:US2010/48610,2010,A1,.Locationinpatent:Page/Pagecolumn73

[2]JournaloftheAmericanChemicalSociety,2009,vol.131,#38,p.13860-13869

[3]JournalofMedicinalChemistry,2013,vol.56,#17,p.7025-7048

[4]BioorganicandMedicinalChemistry,2016,vol.24,#16,p.3436-3446

[5]Patent:EP3381925,2018,A1,.Locationinpatent:Paragraph0159;

[6]Patent:US2006/46990,2006,A1,.Locationinpatent:Page/Pagecolumn6

[7]Patent:US2017/112833,2017,A1,.Locationinpatent:Paragraph0539-0540

[8]JournalofMolecularStructure,2017,vol.1147,p.266-280

[9]Patent:US2007/49618,2007,A1,.Locationinpatent:Page/Pagecolumn82

[10]EuropeanJournalofMedicinalChemistry,2013,vol.68,p.233-243

[11]Patent:WO2015/22073,2015,A1,.Locationinpatent:Page/Pagecolumn52

[12]Patent:WO2015/90580,2015,A1,.Locationinpatent:Page/Pagecolumn32

[13]Patent:US2008/300242,2008,A1,.Locationinpatent:Page/Pagecolumn51

[14]BioorganicandMedicinalChemistryLetters,2009,vol.19,#3,p.1004-1008

[15]Patent:WO2010/104899,2010,A1,.Locationinpatent:Page/Pagecolumn143

[16]Patent:WO2009/84970,2009,A1,.Locationinpatent:Page/Pagecolumn73

[17]Patent:US2010/280268,2010,A1,.Locationinpatent:Page/Pagecolumn48

[18]Patent:WO2006/71730,2006,A1,.Locationinpatent:Page/Pagecolumn78

[19]Patent:US6352993,2002,B1,.Locationinpatent:Pagecolumn29-30

[20]JournalofMedicinalChemistry,1997,vol.40,#17,p.2674-2687

[21]Patent:US2003/93866,2003,A1,

[22]Patent:US6455528,2002,B1,

[23]Patent:US2004/97589,2004,A1,

[24]Patent:US2009/23773,2009,A1,.Locationinpatent:Page/Pagecolumn59

[25]Patent:WO2005/35520,2005,A1,.Locationinpatent:Page/Pagecolumn62-63

[26]Patent:WO2006/44823,2006,A2,.Locationinpatent:Page/Pagecolumn166

[27]BioorganicandMedicinalChemistryLetters,2013,vol.23,#22,p.6192-6196

[28]Patent:WO2013/186692,2013,A1,.Locationinpatent:Page/Pagecolumn86;87

[29]EuropeanJournalofMedicinalChemistry,2014,vol.77,p.75-83

[30]Patent:US2015/152069,2015,A1,.Locationinpatent:Paragraph0180;0181

[31]Patent:EP2883875,2015,A1,.Locationinpatent:Paragraph0064

[32]Patent:WO2018/45104,2018,A1,.Locationinpatent:Paragraph00125

Downstream Synthesis Route

[1]CurrentPatentAssignee:YUHANCORPORATION-US6352993,2002,B1Locationinpatent:Pagecolumn30

[2]CurrentPatentAssignee:SHANGHAIUNIVERSITYOFENGINEERINGSCIENCES-CN106366072,2017,ALocationinpatent:Paragraph0062;0063;0064;0090;0091;0092

[3]CurrentPatentAssignee:SHANGHAIUNIVERSITYOFENGINEERINGSCIENCES-CN106366022,2017,ALocationinpatent:Paragraph0051;0052;0056

[4]Chetty,Sarentha;Armstrong,Tom;SharmaKharkwal,Shalu;Drewe,WilliamC.;DeMatteis,CristinaI.;Evangelopoulos,Dimitrios;Bhakta,Sanjib;Thomas,NeilR.[Pharmaceuticals,2021,vol.14,#4]

[5]CurrentPatentAssignee:RIGELPHARMACEUTICALSINC-US2011/130415,2011,A1Locationinpatent:Page/Pagecolumn102

[6]CurrentPatentAssignee:AUROBINDOPHARMALIMITED-WO2018/207120,2018,A1Locationinpatent:Page/Pagecolumn11;12

[7]CurrentPatentAssignee:KANAZAWAUNIVERSITY-JP2019/43882,2019,ALocationinpatent:Paragraph0059;0062

[8]Nitabaru,Tatsuya;Nojiri,Akihiro;Kobayashi,Makoto;Kumagai,Naoya;Shibasaki,Masakatsu[JournaloftheAmericanChemicalSociety,2009,vol.131,#38,p.13860-13869]

[9]CurrentPatentAssignee:SIHUANPHARMACEUTICALHOLDINGSGROUPLTD.-CN105884695,2016,ALocationinpatent:Paragraph0230;0231;0232

[10]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-US2017/8889,2017,A1Locationinpatent:Paragraph0135;0136;0137

[11]CurrentPatentAssignee:NANJINGSANHOMEINVESTMENTGROUPCOLTD-EP3290419,2018,A1Locationinpatent:Paragraph0074;0075

[12]CurrentPatentAssignee:ZHEJIANGYONGTAITECHNOLOGYCOLTD-CN106083536,2016,ALocationinpatent:Paragraph0037;0038

[13]CurrentPatentAssignee:BEBETTERMED-EP3345900,2018,A1Locationinpatent:Paragraph0042

[14]Liang,Yong;Lu,Changsheng;Lu,Shuo;Ma,Jiawei;Ren,Hongyuan;Wang,Bin;Xu,Jingkai;Yan,Hong[ChineseChemicalLetters,2022,vol.33,#5,p.2420-2424]

[15]CurrentPatentAssignee:SUZHOUYASHENSMARTTECH-CN113387935,2021,ALocationinpatent:Paragraph0039;0073-0077

[16]Peacock,D.Matthew;Jiang,Quan;Hanley,PatrickS.;Cundari,ThomasR.;Hartwig,JohnF.[JournaloftheAmericanChemicalSociety,2018,vol.140,#14,p.4893-4904]

[17]Fu,Lihua;Li,Dingzhong;Lu,Hao;Qiu,Renhua;Sun,Tulai;Xing,Chen;Yang,Tianbao[CatalysisCommunications,2022,vol.162]

[18]Hodgson;Nicholson[JournaloftheChemicalSociety,1940,p.1268,1270]Hodgson;Nixon[JournaloftheChemicalSociety,1931,p.981]

[19]Jacquet,Jean-Pierre;Bouzard,Daniel;Cesare,PierreDi;Dolnic,Nicolas;Massoudi,Massoud;Remuzon,Philippe[Heterocycles,1992,vol.34,#12,p.2301-2311]

[20]Nakata,Hisao;Jitsukawa,Fumie;Toyama,Hitomi;Kato,Yuko[OrganicMassSpectrometry,1992,vol.27,#6,p.720-723]

[21]Elworthy,ToddR.;Ford,AnthonyP.D.W.;Bantle,GaryW.;MorgansJr.,DavidJ.;Ozer,RachelS.;Palmer,WylieS.;Repke,DavidB.;Romero,Magarita;Sandoval,Leticia;Sjogren,EricB.;Talamás,FranciscoX.;Vazquez,Alfredo;Wu,Helen;Arredondo,NicolasF.;BlueJr.,DavidR.;DeSousa,Andrea;Gross,LisaM.;Kava,M.Shannon;Lesnick,JohnD.;Vimont,RachelL.;Williams,TimothyJ.;Zhu,Quan-Ming;Pfister,JürgR.;Clarke,DavidE.[JournalofMedicinalChemistry,1997,vol.40,#17,p.2674-2687]

[22]CurrentPatentAssignee:PAINCEPTORPHARMACORPORATIONINC-US2009/23773,2009,A1Locationinpatent:Page/Pagecolumn59

[23]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2012/151561,2012,A1Locationinpatent:Page/Pagecolumn60

[24]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2013/169401,2013,A1Locationinpatent:Page/Pagecolumn61-62

[25]Liu,Haidong;Lv,Yongfeng;Li,Yuan;Cai,Jin;Chen,Junqing;Qin,Yu;Ji,Min[JournalofChemicalResearch,2015,vol.39,#6,p.318-320]

[26]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2015/175632,2015,A1Locationinpatent:Paragraph447

[27]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2015/195228,2015,A1Locationinpatent:Paragraph454

[28]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN105524068,2016,ALocationinpatent:Paragraph0181;0182

[29]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN105503827,2016,ALocationinpatent:Paragraph0070;0071

[30]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2016/183278,2016,A1Locationinpatent:Paragraph00394;00395

[31]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-US2017/57957,2017,A1Locationinpatent:Paragraph0209-0210

[32]CurrentPatentAssignee:ZHENGZHOUTETRANOVPHARMACEUTICAL;TETRANOVPHARMACEUTICAL;ZHENGZHOUTETRANOVMEDICINE-CN106083736,2016,ALocationinpatent:Paragraph0096;0103

[33]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-EP3173412,2017,A1Locationinpatent:Paragraph0112;0113

[34]CurrentPatentAssignee:TYKMEDICINES;DEURACORTHERAPEUTIC;ZHEJIANGTONGYUANKANGMEDICINE-CN108558835,2018,ALocationinpatent:Paragraph0048;0049

[35]CurrentPatentAssignee:DEURACORTHERAPEUTICS;ZHEJIANGTONGYUANKANGMEDICINE-CN110950847,2020,ALocationinpatent:Paragraph0052;0053

[36]Aitken,Laura;Benek,Ondrej;Chribek,Matej;Dolezal,Rafael;Gunn-Moore,Frank;Hrabinova,Martina;Hroch,Lukas;Jun,Daniel;Kralova,Vendula;Kuca,Kamil;Lycka,Antonin;Musilek,Kamil;Prchal,Lukas;Schmidt,Monika;Vinklarova,Lucie;Zemanova,Lucie[InternationalJournalofMolecularSciences,2020,vol.21,#6]

[37]Mishiro,Kenji;Nishii,Ryuichi;Sawazaki,Izumi;Sofuku,Tomoki;Fuchigami,Takeshi;Sudo,Hitomi;Effendi,Nurmaya;Makino,Akira;Kiyono,Yasushi;Shiba,Kazuhiro;Taki,Junichi;Kinuya,Seigo;Ogawa,Kazuma[JournalofMedicinalChemistry,2022,vol.65,#3,p.1835-1847]

[1]OrganicMassSpectrometry,1992,vol.27,p.720-723

[2]Patent:US4801717,1989,A

[1]Patent:US2011/130398,2011,A1.Locationinpatent:Page/Pagecolumn60

[2]Patent:US2011/269809,2011,A1.Locationinpatent:Page/Pagecolumn12

[3]Patent:US2012/46306,2012,A1.Locationinpatent:Page/Pagecolumn36

[4]Patent:US2012/71499,2012,A1.Locationinpatent:Page/Pagecolumn10

[5]BioorganicandMedicinalChemistry,2014,vol.22,p.4001-4009

[6]Patent:CN105884695,2016,A.Locationinpatent:Paragraph0266;0267;0268

[7]OrganicLetters,2008,vol.10,p.997-1000

[8]Patent:US2017/112833,2017,A1.Locationinpatent:Paragraph0914-0915

[9]JournalofHeterocyclicChemistry,1989,vol.26,p.1547-1554

[10]EuropeanJournalofMedicinalChemistry,2013,vol.68,p.233-243

[11]Patent:WO2007/4749,2007,A1.Locationinpatent:Page/Pagecolumn130

[12]Patent:US6344570,2002,B1.Locationinpatent:Example67

[13]Patent:WO2006/44823,2006,A2.Locationinpatent:Page/Pagecolumn166-167

[14]Patent:WO2018/45104,2018,A1.Locationinpatent:Paragraph00125

[1]Naito;Goto;Akahoshi;Ono;Yoshitomi;Okano;Sugiyama;Abe;Hanada;Hirata;Watanabe;Fukaya;Yokoyama;Fujita[ChemicalandPharmaceuticalBulletin,1991,vol.39,#9,p.2323-2332]

[2]CurrentPatentAssignee:ZHEJIANGYONGTAITECHNOLOGYCOLTD-CN106083536,2016,ALocationinpatent:Paragraph0035;0036

[3]Jacquet,Jean-Pierre;Bouzard,Daniel;Cesare,PierreDi;Dolnic,Nicolas;Massoudi,Massoud;Remuzon,Philippe[Heterocycles,1992,vol.34,#12,p.2301-2311]

[4]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2010/71885,2010,A1Locationinpatent:Page/Pagecolumn443

[5]CurrentPatentAssignee:MERCK&COINC-WO2010/115688,2010,A1Locationinpatent:Page/Pagecolumn146

[1]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN110590548,2019,ALocationinpatent:Paragraph0032-0034;0111-0113

[2]Naito;Goto;Akahoshi;Ono;Yoshitomi;Okano;Sugiyama;Abe;Hanada;Hirata;Watanabe;Fukaya;Yokoyama;Fujita[ChemicalandPharmaceuticalBulletin,1991,vol.39,#9,p.2323-2332]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:448-19-1 Molecular Formula|448-19-1 MDL|448-19-1 SMILES|448-19-1 5-Fluoro-2-nitroanisole |Fluorinated_Building_Blocks